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Soil from a Superfund site (Reilly Tar Site, St. Louis Park, Minnesota) contaminated with
polycyclic aromatic hydrocarbons (PAHs) from creosote was treated with several bioremediation
technologies including bioslurry (BS), biopile (BP), compost (CMP), and land treatment (LT). These
treatment technologies are being evaluated in pilot scale laboratory systems by the U.S.
Environmental Protection Agency's National Risk Management Research Laboratory in Cincinnati,
Ohio. To evaluate the genotoxicity and identify the mutagens in the soil before and after the
various treatments, fractionated extracts of five soils were bioassayed for mutagenic activity with
a microsuspension modification of the Salmonella histidine reversion assay. Soils were extracted
by sonication using dichloromethane (DCM). The five extracts were fractionated in triplicate (two
for bioassay and one for chemical analysis) by reverse-phase high-performance liquid
chromatography (HPLC) using hexane/DCM/methanol, and the fractions for bioassay were
solvent-exchanged into dimethyl sulfoxide by nitrogen evaporation. Forty HPLC fractions for each
sample were bioassayed in strain YG1041 with and without exogenous liver metabolic activation.
As shown in a companion paper, the mutagenicity of two treatments (BS and BP) was
significantly greater than the mutagenicity of the untreated soil. Mutagenic fractions (>500
revertants) were analyzed by gas chromatography/mass spectrometry (GC/MS). PAH analysis of
the soils indicated that all treatments were effective in reducing the total PAH concentration
(48-74%). Qualitative GC/MS analysis of the mutagenic fractions from the BS and BP treatments
indicated that they contained azaarenes, which are mutagens. The CMP and LT processes were
the most effective and least toxic bioremediation procedures based on mutagenic potency and
chemical analysis. This research demonstrated that the combination of bioassays and chemical
analysis provided a more accurate determination of toxicity in these complex environmental
mixtures. Environ Health Perspect 106(Suppl 6):1435-1440 (1998). http.//ehpnetl.niehs.nih.gov/
docs/l998/Suppl-6/1435-1440brooks/abstract.html
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There are over 700 wood-preserving
facilities documented in the United States
(1,2). Many designated Superfund sites are
a result ofwood treatment activities involv-
ing creosote (1,2). During the pressure
treatment ofwood products, excess creosote
is released from the treated materials, and
the leaching ofcreosote wastes from treated
materials contaminating the soil and
groundwater has been common (1,2). One
such contaminated site is in St. Louis Park,
Minnesota, the former site ofthe Reilly Tar
and Chemical Corporation's coal tar
distillation and wood preserving plant.
From 1917 to 1972, dumping from this
plant contaminated about 80 acres of soil
and the underlying groundwater with
creosote wood-preserving waste (3). In
1978, the Minnesota Department of
Health discovered significant concentra-
tions of polycyclic aromatic hydrocarbons
(PAHs) in six municipal drinking water
wells near the Reilly Tar Site plant (3).
Currently, St. Louis Park is pumping and
treating the contaminated groundwater
plume leaching from the creosote-conta-
minated soil and has placed a soil cover
with grass over the contaminated soil.
To reduce the length of time required
for pump and treat operations, the U.S.
Environmental Protection Agency (U.S.
EPA) National Risk Management Research
Laboratory (Cincinnati, Ohio) is evaluating
various bioremediation technologies for
their efficiency in removing PAHs and
reducing toxicity ofsoil collected from St.
Louis Park. The bioremediation technolo-
gies that are being examined in pilot-scale
laboratory studies are bioslurry (BS), biopile
(BP), compost (CMP), and land treatment
(LT). These technologies are presented and
described by Hughes et al. (4). The goal of
these bioremediation technologies is to
reduce the PAH concentrations and toxicity
ofcontaminated soils. The PAH concentra-
tions were chemically monitored through-
out this study. The mutagenic activity ofthe
soil extracts was measured in the untreated
soil (UTS) and in the four treatment soils at
end of the study. Mutagenic activity was
measured using the Salmonella mutagenicity
assay developed by Maron and Ames (5).
The bioassay indicated higher mutagenicity
in the BS (163.3x 106 revertants [rev]/kg
dry soil) and BP (3.0x 106 rev/kg dry soil)
treatments than in the UTS (0.008x 106
rev/kg dry soil) (4). A significant increase in
mutagenicity in the CMP and LT extracts
This paper is based on a presentation at the Conference on Current Issues on Chemical Mixtures held 11-13 August 1997 in Fort Collins, Colorado. Manuscript received
at EHP 17 February 1998; accepted 30 June 1998.
The authors thank L. Stephens, A. Warren, P. Matthews, H. Carlsen, and B. Eischen for their valuable assistance. The Reilly Tar Site samples were prepared by the fol-
lowing people at the U.S. Environmental Protection Agency (U.S. EPA) in Cincinnati, Ohio: untreated soil (P. McCauley), bioslurry (J. Glaser), biopiles and compost (C.
Potter), and land treatment (G. Sayles). The authors thank them for supplying soil samples and the chemical analysis (percent reduction in PAH) for this study. The
authors thank J. Ryan and E. George for their critical technical review of the manuscript.
Address correspondence to L.R. Brooks, Environmental Carcinogenesis Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental
Protection Agency, MD-68, Research Triangle Park, NC 27711. Telephone: (919) 541-1365. Fax: (919) 541-3966. E-mail: brooks.lance@epamail.epa.gov
Abbreviations used: BP, biopile; BS, bioslurry; CMP, compost; DCM, dichloromethane; DMSO, dimethyl sulfoxide; GC/MS, gas chromatography/mass spectrometry;
HPLC, high-performance liquid chromatography; LT, land treatment extract; rev, revertants; +S9, with aroclor-induced rat liver; -S9, without arochlor-induced rat liver;
PAH, polycyclic aromatic hydrocarbon; U.S. EPA, U.S. Environmental Protection Agency; UTS, untreated creosote-contaminated soil.
Environmental Health Perspectives * Vol 106, Supplement 6 * December 998 1435BROOKS ETAL.
compared to the UTS was not detected (4).
In this study the mutagenic BS and BP
extracts, along with the UTS extracts, were
fractionated by high-performance liquid
chromatography (HPLC) and the result-
ing mutagenic fractions were analyzed by
gas chromatography/mass spectrometry
(GC/MS) to identify the mutagens
present in the BS and BP.
Materials and Methods
SoilExaction
Five soil samples from the end ofthe study
(UTS, BS, BP, CMP, and LT) were placed
individually in glass jars, as described by
Hughes et al. (4). Twice the volume of
dichloromethane (DCM) (GC grade,
Burdick & Jackson, Muskegon, Michigan)
was added to each jar. Each sample was
sonicated for 15 min and the extract was
decanted into a glass collection vessel. This
procedure was repeated twice more. Each
organic extract was then dried ofwater
with sodium sulfate and filtered through a
0.45-pm Teflon filter (Millipore, Marl-
borough, Massachusetts). Sample volume
was reduced by rotoevaporation and nor-
malized to 25 ml. The concentration of
each extract was then determined by gravi-
metric analysis (milligrams oforganics per
milliliter DCM).
PolycycicAromatic
HydrocbonAnalysis
A 40-ml volatile organic analysis vial served
as the extraction vessel. Four grams ofthe
soil was mixed with 10 gsodium sulfate and
1000 pg surrogate (2-fluorobiphenyl) (two
to six replicates ofeach treatment were used
for analysis). After mixing the soil and
sodium sulfate, 20 ml of a DCM/acetone
extraction solvent mixture was added to the
vial. The vial was then placed on a recipro-
cating shaker for 18 hr. After the vial was
centrifuged at 1500 rpm for 30 min, a 1-ml
aliquot was removed for GC analysis. U.S.
EPA method 8100 (6) was used to quantify
19 PAHs in the sample extracts. A Hewlett-
Packard 5890A gas chromatograph
(Hewlett-Packard, Wilmington, Delaware),
a Supelco SPB-5 column (Supelco,
Bellefonte, Pennsylvania) (30 mx0.53 mm,
0.50-pm film thickness), and a flame
ionization detectorwere usedforthis analysis.
i1gb-Performance Liquid
ChromatographyFractionation
For fractionation, 5 mg ofeach ofthe five
soil extracts was injected onto a silica
column (Econsil Silica, 10 pm, 250x 10
mm, Alltech, Deerfield, Illinois). The
extracts were eluted at 7 ml/min using a
Waters 600E HPLC (Millipore) equipped
with a 717 autosampler, a M996 photodi-
odearray detector, and an Isco Foxy Jr.
(Isco, Lincoln, Nebraska) fraction collector.
The gradient initially was 99% hexane
(HPLC grade, Burdick & Jackson) and 1%
DCM, which was held for 5 min. This was
followed by a linear gradient to 100%
DCM in 20 min and then held for 1 min.
This was followed by a linear gradient to
100% methanol (HPLC grade, Burdick &
Jackson) in 5 min and then held for 10 min.
Fractions were collected at the rate of 1/min
during the 40-min run in 8-ml vials con-
taining 5 pl dimethyl sulfoxide (DMSO) for
bioassay. The vials contained no DMSO
when collected for chemical analysis. The
resulting fractions were then concentrated
by nitrogen evaporation.
MutagenicityAssay
Whole extracts ofthe five soils (UTS, BS,
BP, CMP, LT) were bioassayed in the plate
incorporation assay using strains YG1041
and YG1042 with and without exogenous
mammalian metabolic activation (S9) (4).
The HPLC fractions were bioassayed in a
microsuspension modification of the
Salmonella mutagenicity assay (4,7) using
strain YG1041. Hughes et al. (4) showed
that YG1041 was the most sensitive strain
for detecting mutagenicity of the whole
extracts from the Reilly Tar Site. The
extracts and fractions were bioassayed with
arochlor-induced rat liver (+S9) andwithout
arochlor-induced rat liver (-S9) metabolic
activation according to the method of
DeMarini (8). Briefly, 100 pl of 10-fold
concentrated cells in buffer (from 16-hr cul-
tures) and 100 pl of 0.015 M phosphate
buffer or 100 pl S9 mix (6%), pH 7.2, were
added to each fraction that had been
solvent-exchanged into 5 pl DMSO.
Contents of the tubes were mixed, incu-
bated at 370C for 90 min, then poured onto
minimal medium plates. 2-Nitrofluorene
(0.3 pg/plate) served as the positive control
for YG1041 (-S9) and yielded a mean of
204 rev. 2-Aminoanthracene was the posi-
tive control for YG1041 (+S9) with 0.25 pg
yielding 738 rev. Solvent (DMSO) control
values for YG1041 were 109 (-S9) and 106
(+S9). A laboratory blank (DCM) was also
tested as a control for the HPLCsystem.
Gas Chromatography/lass
SpectrometryAnalysis
For qualitative GC/MS analysis, a total of
25 mg for each extract (UTS, BS, BP) was
fractionated. The HPLC fractions were
evaporated to dryness and then dissolved
into 100 pl DCM. The fractions were
then analyzed using a Hewlett-Packard
5890 gas chromatograph with a 5973 mass
spectrometer interfaced to a dedicated data
system. The gas chromatograph oven con-
tained an HPB-5ms column (30 mx0.25
mm, 0.25-pm film thickness) (Hewlett
Packard), which was at 40°C initially and
then increased to 300°C at a rate of
5°C/min. GC/MS data were acquired
from 35 to 500 atomic mass units. The
results interpretation was done on the
basis of data collected in a computer
library containing 275,821 mass spectrom-
etry spectra (9). All identifications are
tentative, as no authentic standards were
used for comparison.
Results
Polycyclic aromatic hydrocarbon analysis
of the soils before and after each treat-
ment demonstrated observable decreases
(from 48 to 74%) in the concentrations of
priority pollutant PAHs, as seen in Table
1. The greatest reduction (59 to 92%) was
in the two- and three-ring PAHs for all
treatments. The next greatest reduction
(40 to 75%) was in the four-ring PAHs.
The percent reduction (-10 to 20%) in
the five- and six-ring PAHs indicated no
real change in these concentrations.
Higher-ring PAHs take longer to be
degraded (10) because ofthe induction of
complex biodegradation enzymes in
microorganisms, low solubility, and sorp-
tion to the soil. The largest average reduc-
tion in total PAHs for the four extracts
tested in the mutagenicity assay was in the
CMP (74%), followed by the BS (62%),
LT (62%), and BP treatments (48%).
After the bioassay ofeach fraction was
completed, the resulting mutagenicity
profile ofthe HPLC fractions constituted a
mutagram (11). Mutagrams from all four
bioremediation treatments, UTS, and a
solvent (DCM) method blank, bioassayed
in the Salmonella mutagenicity assay in
YG1041 +S9 and -S9, are shown in
Figures 1 and 2. The average mutagenicity
ofthe solvent blank fractions was 138±55
rev +S9 and 131 ±41 rev -S9. A treatment
fraction was not considered mutagenic
unless it was .500 rev (greater than three
times the solvent blank) per fraction. The
BS treatment had the most mutagenic frac-
tions (both revertants per fraction and the
number of fractions) both +S9 and -S9.
The BP treatment showed less mutagenicity
(both revertants per fraction and the
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Table 1. Polycyclic aromatic hydrocarbon concentration of thefour treatment soils.a
Average initial Average final
concentration, concentration, Percent
Soil treatment mg/kg soil mg/kg soil reduction
Bioslurry
Two- and three-ring PAHsb 443±62 114±75 74
Four-ring PAHsc 874±219 217±81 75
Five- and six-ring PAHsd 388±90 309±71 20
Total PAHs 1705±361 640±161 62
Biopile
Two- and three-ring PAHs 1490±183 458±159 69
Four-ring PAHs 1094±85 651 ±253 40
Five- and six-ring PAHs 408±75 450±49 [1i0ie
Total PAHs 2992±326 1559±726 48
Compost
Two- and three-ring PAHs 2628±57 217±23 92
Four-ring PAHs 1245±35 468±9 62
Five- and six-ring PAHs 444±40 457±3 [3Ve
Total PAHs 4317±132 1142± 11 74
Land treatment
Two- and three-ring PAHs 1232 ± 111 295±102 76
Four-ring PAHs 1126±73 361 ±243 68
Five- and six-ring PAHs 438±116 399±159 68
Total PAHs 2796±292 1055±719 62
Untreated soil
Two- and three-ring PAHs 1580±75 NA NA
Four-ring PAHs 880±44 NA NA
Five- and six-ring PAHs 325±134 NA NA
Total PAHs 2785±230 NA NA
aAs determined by U.S. EPA method 8100 (6). bTwo- and three-ring PAHs include naphthalene, 2-methyinaphtha-
lene, acenaphthylene, acenaphthene, dibenzofuran, fluorene, phenathrene, and anthracene. cFour-ring PAHs
include fluoranthene, pyrene, benzo[alanthracene, and chrysene. dFive- and six-ring PAHs include benzo[b]fluoran-
thene, benzo[k]fluoranthene, benzo[e]pyrene, benzo[alpyrene, indeno[123-cd]pyrene, dibenzo[a,h]anthracene, and
dibenzo[g,h,l]perylene. 'Denotes an increase in concentration.
number offractions) than the BS treatment
but was more mutagenic than the other
treatments (CMP, LT) and the UTS. The
mutagenicity of the CMP and LT frac-
tions was not qualitatively different from
that in the UTS fractions both in our
study and in Hughes et al. (4). Therefore,
extracts from these two treatments were
not chemically analyzed.
GC/MS identification ofcompounds in
the mutagenic fractions from the BS and BP
HPLC fractionations is summarized in
Table 2. The HPLC fractionations from the
UTS also were analyzed by GC/MS for
comparison to the BS and BP fractions and
are included in Table 2. The priority pollu-
tant PAHs (listed in Table 1) only were
detected in three fractions for both the BS
and BP treatments. In both the BS and the
BP treatments, fraction 16 contained
acenaphthene and fractions 30 and 31
contained acenaphthylene, anthracene,
benzo[a]anthracene, and chrysene. Fraction
16 ofthe UTS contained acenaphthene, and
fraction 31 contained acenaphthylene and
benzo[a]anthracene. The other compounds
seen in the remaining BS and BP fractions
were mainly N-heterocyclics (italicized in
Table 2) such as acenaphthopyridine,
acridine, 1-azapyrene, benzo(c)carbazole,
benzoquinoline, benzothiazolylphenol,
carbazoles, diaminotriazole, diphenylpyra-
zole, indenopyridine, methylacridine,
methylazaphenanthrene, methylbenzacri-
dine, and methylisothiazole. Some fractions
also contained S- and 0- heterocyclics such
as benzothiazolylphenol, benzocoumarin,
benzofuranol, fluoroscein, methylisothiazole,
and phenanthrofuran (Table 2).
Discussion
It has been estimated that creosote
consists of 85% PAHs, 10% phenolics,
and 5% other N-, S-, and O-heterocyclics
(1). In this study, the bioremediation
treatments (BP, BS, CMP, and LT) were
successful in reducing the priority pollu-
tant PAHs by 48% or more (Table 1).
However, when the soil extracts from the
bioremediation treatments and the UTS
(extracted at the same time as the treat-
ment soils) were tested in the Salmonella
mutagenicity assay in strain YG1041, two
treatments (BS and BP) had increased
mutagenic activity, both with and without
S9 addition, when compared to UTS (4).
All four bioremediation treatments and
the UTS were fractionated by HPLC and
tested in a microsuspension modification
ofthe Salmonella mutagenicity assay using
* Bioslurry (59S) 0 Land treatment (-S9)
* Biopiles (-S9) A Blank (-S9)
oI Compost (-S91 vUntreated 1-S91
50 0
c,
0 5 10 15 20 25 30 35 40
Fractions
Figure 1. Mutagram of high-performance liquid chromatography fractions tested in
the Salmonella mutagenicity assaywithout metabolic activation (-S9).
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* Bioslurry (-S9) 0 Land treatment(-S9)
* Biopiles(-S9) A Blank (-S9)
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Fractions
Figure 2. Mutagram of high-performance liquid chromatography fractions tested in
the Salmonella mutagenicity assaywith metabolic activation (+S9).
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Table 2. Results ofthe gas chromatography/mass spectrometry analysis of the mutagenic high-performance liquid chromatography fractions.a
Fraction
no. Untreated soil Bioslurry Biopile
14 Notanalyzed Methylatedandoligomethylated Methylatedandoligomethylated
9H-carbazole,
benzo[c]carbazole
Acenaphthene,
benzo[c]carbazole,
anthracenecarbonitrile
Benzoquinoline, antracenedione,
cyclopenta(deflphenanthrenone,
fluorenecarbonitrile
9H-fluoren-9-one, anthracenone
Dihydrocyclobuta[b]naphthalene
Benzanthracenone,
dihydrocyclobuta[b]naphthalene,
naphthopyrandione
No identified compounds
No identified compounds
Notanalyzed
Acenaphthylene,
benzo[a]anthracene,
benzo[c]acridine, hexanediol,
dihydroindenone,
acenaphthopyridine,
methylindanone,
demethylfurylpuridine,
naphthopyran, indenquinoline,
phenylcarbazole
carbazoles, naphazulenone,
indenoanthracenone
9H-carbazole, acenaphthalene,
methylbenzacridine
Acenaphthene,
benzo[c]carbazole,
anthracenecarbonitrile,
benzanthracenone,
fluorenecarbonitrile,
1-azapyrene
Tetramethylphenol, fluoroscein,
9,10-anthraquinone,
indacenedione, benzanthracenone
Benzoquinoline,
cyclopentaphenanthrenone,
hydroxypyrene, anthracene dione,
cyanopyrene, benzothiazolylphenol
Benzanthracenone, diphenylpyrazole
2-Hexanol, methylcyclopentanone,
tetrachloroethane,
3-methylpentanone, diaminotriazole
Dihydrocyclobuta[b]naphthalene,
phenanthrofuran
No identified compounds
Acenaphthylene, anthracene,
dihydroindenone, pyrene, chrysene,
hexanols, heptanols, hexones, heptanones,
methylisothiazole, acenaphtylenedione,
anthracendiamine, benzoanphthothiophene
Acenaphthylene,
benzo[a]anthracene, anthracene,
chrysene, hexanediol,
dihydroindenone,
acenaphthopyridine,
2-pentanone, indenopyridine,
acridine, methylacridine,
methylazaphenanthrene,
naphthopyrandione,
anthracenecarbonitrile, palmitic acid
carbazoles, benzonitrile,
phenylquinoline
9H-carbazole
Acenaphthene,
benzo[c]carbazole,
anthracenecarbonitrile,
benzanthracenone,
fluorenecarbonitrile,
phenethrol,
indenoisoquinoline,
hydroxy-thienyl-quinoline
Anthracenecarbonitrile,
aromatic ketones
Aromatic ketones
Benzanthracenone
2-Hexanol, benzanthracenone,
tetrahydrophenanthrenone,
styrylquinoline,
therahydrobenzanthracene,
phenanthrofuran
Phenanthrofuran,
aromatic ketones
Phenthrofuran, benzofuranol,
benzocoumarin
Acenaphthylene anthracene,
dihydroindenone, methylindene,
aliphatic ketones and alcohols
Acenaphthylene,
benzo[alanthracene,
benzo[clacridine,
anthracene, chrysene
aCompounds in italics are azaarenes.
strain YG1041, which yielded mutagrams
(Figures 1 and 2). Again, the two treat-
ments (BS and BP) had increased muta-
genicity as compared to the UTS,
especially in 11 of 40 fractions of the BS
(+S9, -S9) and in 6 fractions of the BP
(+S9, -S9) (Figures 1 and 2).
To determine the cause ofthe increased
mutagenicity in these two treatments, the
mutagenic HPLC fractions, along with
corresponding fractions from the UTS, were
analyzed by GC/MS. Ofthe 11 mutagenic
fractions of the BS and BP treatments
analyzed by GC/MS, only 3 fractions
contained any of the priority pollutant
PAHs (Table 1). The mutagenicity (+S9)
seen in fractions 30 and 31 of the BS and
BP treatments is likely due to PAHs that
are positive in the Salmonella mutagenic-
ity assay (Table 3). The mutagenicity in
other fractions, therefore, must be attrib-
uted to compounds other than the 19
priority PAHs. Many of the other com-
pounds identified by GC/MS in the frac-
tions are azaarenes (i.e., PAHs where a
nitrogen replaces a carbon in the ring
structure). Several of these azaarenes
(acridine, 1-azapyrene, diaminotriazole, and
methylazaphenanthrene) are mutagenic -S9
(Table 3).
Nitroarenes are another class of
chemicals that were of concern in these
samples. Many nitroarenes (i.e., a nitro
group attached to a PAH) are direct-acting
mutagens (i.e., they do not need S9 to be
mutagenic). For a review of their muta-
genicity see Rosenkranz and Mermelstein
(17). Nitroarenes are metabolized by the
bacterial enzymes nitroreductase and
Environmental Health Perspectives * Vol 106, Supplement 6 * December 1998
15
16
18
20
23
24
25
27
30
31
1438BIOASSAY-DIRECTED FRACTIONATION OF BIOREMEDIATED SOILS
Table 3. Identified compounds tested in the Salmonellamutagenicity assay.ab
Fraction Bioslurry Biopile
no. Compound Result Reference Compound Result Reference
14 No identified mutagens in the literature No identified mutagens in the literature
15 9H-carbazole Negative (12) 9H-carbazole Negative (12)
16 Acenaphthene Negative (13) Acenaphthene Negative (13)
Benzanthrone Positive, -S9 (12) Benzanthrone Positive, -S9 (12)
1-Azapyrene Positive, -S9,+S9 (12,14)
18 Fluorescein Negative (12,15) No identified mutagens in the literature
20 Anthracene dione Positive, -S9,+S9 (12) No identified mutagens in the literature
23 No identified mutagens in the literature No identified mutagens inthe literature
24 Diaminotriazole Positive, -S9,+S9 (12) No identified mutagens in the literature
25 No identified mutagens in the literature No identified mutagens in the literature
27 No identified mutagens in the literature No identified mutagens in the literature
30 Pyrene Negative (12,15) Acenaphthylene Positive, +S9 (12)
Chrysene Positive,+S9 (12,16) Anthracene Positive, +S9 (13,15)
Hexone Negative (13)
31 Acenaphthylene Positive, +S9 (12) Acenaphthylene Positive, +S9 (12)
Benzo[alanthracene Positive, +S9 (15) Benzo[alanthracene Positive, +S9 (15)
Anthracene Positive, +S9 (13,15) Anthracene Positive, +S9 (13,15)
Chrysene Positive, +S9 (12,16) Chrysene Positive, +S9 (12,16)
Acridine Positive, -S9 (12)
Methylazaphenanthrene Positive, -S9, +S9 (12,16)
aResults are shownonly forthe mutagenic fractions. bCompounds in italics are azaarenes.
acetyltransferase. Salmonella strains
YG1041 and YG1042 were developed from
the standard Salmonella tester strains TA98
and TAIOO (5), respectively, and they con-
tain elevated levels (50x) ofboth nitrore-
ductase and acetyltransferase activities (7).
Ifhigher mutagenic activity is detected in
these strains than in TA98 and TA100,
especially without S9 addition, the presence
of nitroarenes could account for the muta-
genicity in the test sample. This condition
was true for the BS and BP extracts in this
study. The BS had mutagenic slopes (rever-
tants per microgram; calculated from the
linear regression ofthe data) of38.6 (-S9)
and 31.4 (+S9), and the BP had mutagenic
slopes of 3.0 (-S9) and 5.0 (+S9) (4). In
addition, when TA98NR (which lacks
nitroreductase and has limited ability
to metabolize nitroarenes into active
mutagens) was used, the mutagenic activity
ofthe BS extract was reduced by 50% when
mutagenic results were compared to TA98,
which contains normal Salmonella nitrore-
ductase (4). Therefore it was hypothesized
from these data that the mutagenic activity
in the BS extract may be due to nitroarenes.
This hypothesis, however, was not upheld
by chemical analysis. The mutagenic HPLC
fractions in the BS and BP extracts were
analyzed by GC/MS and nitroarenes were
not detected; however, azaarenes were
detected (Table 2). Nitroarenes can be
detected as mutagens at nanogram levels in
strains YG1041 and YG1042 (7). The
detection limits of the GC/MS were not
low enough to detect any nitroarenes that
may have been present in the BS. Examples
of the azaarenes found in these fractions
were acenaphthopyridine, acridine, 1-aza-
pyrene, benzo[c]carbazole, benzoquinoline,
benzothiazolylphenol, carbazoles, diamino-
triazole, diphenylpyrazole, indenopyridine,
methylacridine, methylazaphenanthrene,
methylbenzacridine, and methylisothiazole.
A large number of azaarenes have been
reported in various creosotes (18) and in
creosote-contaminated soil (19). The
azaarenes are of concern because of their
mutagenic activity and because the nitrogen
atom in the ring system causes these com-
pounds to beweakly polar and considerably
more water soluble than related PAHs.
Azaarenes have been reported in ground-
water near creosote-contaminated sites
including the Reilly Tar Site (1,2,10).
One reason the BS treatment was much
more mutagenic than the other treatments
could be that it was amended with 1%
activated sludge (primary solid waste aer-
ated and stirred to encourage bacterial
growth) from a municipal wastewater-
treatment facility that processed both
industrial and municipal waste (4). The
sludge was added in an effort to increase
the diversity of the bacterial population in
the BS. Municipal wastewater and sludge
from municipal wastewater-treatment
facilities contain azaarenes, oxygenated
PAH derivatives, and nitroarenes (21-23).
Azaarenes were also detected in BS frac-
tions 20 and 24 (Table 2) and may have
been increased in the BS by the addition of
the activated sludge. For example, acridine,
1-azapyrene, diaminotriazole, and methy-
lazaphenanthrene were uniquely identified
in the BS. All have been cited as direct-
acting mutagens (Table 3). The mutagenic
fractions for the BS in Figure 2 may be due
to these compounds and the higher
number of PAHs in the BS. In addition,
acridine, fluorescein (dyes), and tetra-
chloroethane (an industrial product) were
identified in BS fractions 31, 18, and 24,
respectively. The presence of these three
compounds may be evidence that the acti-
vated sludge added to the BS contained
industrial chemicals.
Another possible reason the BS was
more mutagenic than the other treatments
was that the BS was the only treatment
that was constantly aerated and mixed.
The BS had air bubbled to the bottom of
the reaction vessels at the rate of 1.5
ml/min and was stirred at 500 rpm (4).
BS had 1% activated sludge added and BP
had 1% cow manure added in an effort to
increase the diversity ofthe bacterial pop-
ulation. The constant aeration in the BS
caused maximum mixing of all compo-
nents, including the azaarenes. The BP
contained azaarenes but mixing did not
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occur. CMP had 1% cow manure added,
but the treatment vessel was not aerated,
and was mixed once a day by rolling the
vessel for 30 min. LT had nothing added
and was tilled once per week. Each of
these processes, therefore, had different
levels ofanaerobic and aerobic metabolism
occurring. The differences in aeration,
mixing, and addition of sludge/manure
between the mutagenic treatments (BS,
BP) and the other nonmutagenic treat-
ments (CMP, LT) may account for the
mutagenicity. Weak mutagenic activity
was also detected in all five extracts in
TA102 (4). This strain detects mutagenic
aldehydes and ketones, which were
detected in the BS and BP (Table 2).
Conclusion
The pilot scale laboratory experiments of
the creosote-contaminated field soil were
conducted to determine which treatment
was most successful not only in reducing
the total PAH concentration but also the
toxic potential ofthis soil. The PAH analy-
sis demonstrated that each treatment was
successful in reducing the total PAH
concentration. However, the mutagenic
activity demonstrated that some treatments
(BP and BS) actually increased the toxic
potential of these soils. Also, chemical
analysis along with the bioassay identified
several problems. The initial PAH concen-
trations (Table 1) varied among the treat-
ments and were due to the different sieving
sizes (1/4 to 1 in) used for each ofthem. In
the future, uniform particle sizes should be
used to more accurately compare the treat-
ments. Also, the increased mutagenicity in
the treatments (BP and BS) could not be
directly associated with the amendments
(i.e., activated sludge) added to these treat-
ments because they were not analyzed
directly in the chemical analysis and the
mutagenicity assay. Amendments should
be evaluated for toxicity before addition to
a bioremediation process to ensure that
they are nontoxic. Complex environmental
mixtures such as these soil extracts can
contain hundreds of chemicals. Bioassay-
directed fractionation is an efficient
method to identify signature mutagenic
chemicals in such mixtures. The combina-
tion ofbioassays and chemical analysis pro-
vided a more complete and accurate
evaluation of the four bioremediation
treatments in this pilot study.
DISCLAIMER: This manuscript has been
reviewed by the National Health and
Environmental Effects Research Laboratory,
U.S. EPA, and approved for publication.
Approval does not signify that the contents
necessarily reflect the views and policies of
the agency, and the mention oftrade names
or commercial products does not constitute
endorsement or recommendation for use.
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